VNDA R&D Expense Growth
Vanda Pharmaceuticals Inc · R&D Expense Growth
VNDA R&D Expense Growth
Latest reported46.81%period ending
VNDA FY R&D Growth (YoY) (0.00% → 46.81%)
Latest values, visible window
High-resolution chart · PNG
VNDA r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 46.8085% | |
| -3.1137% | |
| -10.4314% | |
| 13.8092% | |
| 35.6011% | |
| 14.2408% | |
| 11.5956% | |
| 13.0931% | |
| 32.2095% | |
| 0.0377% | |
| 51.5601% | |
| -31.7843% | |
| -37.9703% | |
| 56.732% | |
| 135.0138% | |
| -11.0708% | |
| -42.0362% | |
| -49.3265% | |
| -9.2872% | |
| 208.2823% | |
| 126.9334% | |
| 0% |